Epidemiology of hepatitis D in patients infected with hepatitis B virus in bucharest: A cross-sectional study

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 769-774

  Popescu, G A ^a   Otelea, D ^a   Gavriliu, L C ^a   Neaga, E ^a   Popescu, C ^a   Paraschiv, S ^a   Fratila, M ^a  

^a National Institute for Infectious Diseases Prof Dr Matei Bals   (Romania)

Author keywords

Bucharest; HBV HDV replication interference; HDV genotypes; HDV prevalence

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; FEMALE; GENE ISOLATION; GENOTYPE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; SUPERINFECTION; VIREMIA; VIRUS LOAD;

EID: 84875675628     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23524     Document Type: Article

References (16)

1. Altuglu I, Ozacar T, Sertoz RY, Erensoy S. 2007. Hepatitis delta virus (HDV) genotypes in patients with chronic hepatitis: Molecular epidemiology of HDV in Turkey. Int J Infect Dis 11:58-62.
2. Beldescu N, Balan A, Popa R. 1995. Prevalenţa markerilor de hepatitǎ viralǎ în populaţia generalǎ. Bacteriol Virusol Parazitol Epidemiol 40:101-108.
3. Dény P. 2006. Hepatitis delta virus genetic variability: From genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol 307:151-171.
4. Gaeta GB, Strofolini T, Chiaramonte M, Ascione T, Stonaiuolo G, Labello S, Sagnelli E, Bonetto MR, Rizzetto M. 2000. Chronic hepatitis D: A vanishing disease? Hepatology 32:824-827.
5. Gheorghe L, Csiki IE, Iacob S, Gheorghe C. 2012. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: A nationwide survey. Eur J Gastroenterol Hepatol 25:56-64.
6. Grigorescu M, Pascu O, Acalovschi M, Radu C. 2003. What is the real prevalence of the D virus infection in chronic hepatitis and liver cirrhosis in Romania? Rom J Gastroenterol 12:179-182.
7. Huang CR, Szecheng JL. 2010. Evolution and diversity of the human hepatitis D virus genome. Adv Bioinformatics 2010:323654.
8. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, Dény P. 2006. Eight major clade for hepatitis delta virus. Emerg Infect Dis 12:1447-1450.
9. Lee SD, Wang JY, Wu JC, Tsay YT, Lo KJ, Lai KH, Tsay SH, Govindarajan S. 1987. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: Immunopathologic and serologic findings. Scand J Infect Dis 19:173-177.
10. Niro GA, Fontana R, Ippolito AM, Andriulli A. 2012. Epidemiology and diagnosis of hepatitis D virus Fut. Virology 7:709-717.
11. Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, Nikolopoulos GK, Malliori M, Salminen M, Suk JE, Griffiths P, van de Laar MJ. 2011. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill 16:pii=20032. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20032
12. Tapalaga D, Forzani B, Hele C, Paravancini O, Panzetto A, Theilmann L. 1986. Prevalence of the hepatitis delta virus in Romania. Hepatogastroenterology 33:238-239.
13. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. 2005. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 77:491-499.
14. Viana S, Parana R, Moreira RC, Compri AP, Macedo V. 2005. High prevalence of hepatitis B virus and hepatitis D virus in the Western brazilian Amazon. Am J Trop Med Hyg 73:808-814.
15. Wedemeyer H. 2011. Hepatitis D revival. Liver Int 31:S140-S144.
16. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloǧlu Y, Deǧertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP, HIDIT Study Group. 2011. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 364:322-331.